Ben Brooker

There is a slaughterhouse-like logic to the way humanity’s mistreatment of animals tends to be written about. Repetitive. Relentless. Atrocity piles upon atrocity, with no hope of remedy. Readers, probably appalled by the abattoir to begin with, likely vegetarians or vegans or animal fosterers, discomfort themselves yet again in the name of … what exactly? Duty? Academic interest? A renewed sense of the righteousness of animal liberation? We read on grimly, plumbing the depths of a despair that would feel commonplace if it didn’t remain, always, so excruciatingly raw.

Clark (no ‘e’) may not feel misunderstood exactly, but his memoir, An Eye for Talent – a diaristic account of his remarkably enduring directorship of the National Institute of Dramatic Art (NIDA) from 1969 to 2004 – certainly reads like the seizing of an opportunity to burnish the author’s legacy.

This is British environmentalist and writer George Monbiot’s overarching theme in his important new book, Regenesis. While focusing primarily on his native Britain, Monbiot uses a wealth of research – there are almost one hundred pages of notes, and he claims to have read more than 5,000 papers and ‘a shelf of books’ – to argue that the global food production system is in a parlous state. Without comprehensive reform, Monbiot warns, we risk nothing less than the survival of our species.

At sixty-six years of age and best known for his books on the sociology of food, the American author and journalist Michael Pollan has become an unlikely figurehead for the so-called ‘psychedelic renaissance’. In How to Change Your Mind (2018), Pollan surveyed the recent revival of psychedelic drugs as adjuncts to psychotherapy, and the emerging evidence that supports their use in the treatment of depression, PTSD, and other mental health disorders. Globally prohibited since the early 1970s and still mostly illegal, these compounds – including the ‘classic’ psychedelics LSD and psilocybin (the main psychoactive alkaloid in magic mushrooms), as well as MDMA (also known as ecstasy) and ketamine – are once again the subject of clinical trials, including in Australia where the federal government has became one of the first in the world to fund research in the field.

Four kangaroos recently moved into the paddock that adjoins the house on Peramangk Country in the Adelaide Hills where I live. For weeks I had been conscious of distant gunfire, not the usual firing of the gas guns that wineries use to keep birds off their vines. I concluded that the kangaroos had been driven here by a cull. The goats, Charles and Hamlet, and the sheep, Lauren and Ingrid, who call the paddock home, seemed unperturbed by the roos’ presence. But what, I wondered, did all these animals think about one another? What, indeed, did they think about me?